NO20014526L - Farmasöytiske preparater omfattende metallkomplekser - Google Patents
Farmasöytiske preparater omfattende metallkomplekserInfo
- Publication number
- NO20014526L NO20014526L NO20014526A NO20014526A NO20014526L NO 20014526 L NO20014526 L NO 20014526L NO 20014526 A NO20014526 A NO 20014526A NO 20014526 A NO20014526 A NO 20014526A NO 20014526 L NO20014526 L NO 20014526L
- Authority
- NO
- Norway
- Prior art keywords
- metal complexes
- pharmaceutical preparations
- preparations
- pharmaceutical
- complexes
- Prior art date
Links
- 239000002184 metal Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
- C07F15/0053—Ruthenium compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12516699P | 1999-03-19 | 1999-03-19 | |
PCT/CA2000/000294 WO2000056743A1 (en) | 1999-03-19 | 2000-03-17 | Pharmaceutical compositions comprising metal complexes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20014526D0 NO20014526D0 (no) | 2001-09-18 |
NO20014526L true NO20014526L (no) | 2001-10-16 |
Family
ID=22418482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014526A NO20014526L (no) | 1999-03-19 | 2001-09-18 | Farmasöytiske preparater omfattende metallkomplekser |
Country Status (15)
Country | Link |
---|---|
US (1) | US20020049190A1 (no) |
EP (1) | EP1163247A1 (no) |
JP (1) | JP2004500321A (no) |
KR (1) | KR20010112343A (no) |
CN (1) | CN1391577A (no) |
AU (1) | AU3268500A (no) |
BR (1) | BR0011678A (no) |
CA (1) | CA2367282A1 (no) |
CZ (1) | CZ20013307A3 (no) |
HU (1) | HUP0400457A2 (no) |
IL (1) | IL145290A0 (no) |
MX (1) | MXPA01009410A (no) |
NO (1) | NO20014526L (no) |
PL (1) | PL356683A1 (no) |
WO (1) | WO2000056743A1 (no) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ514736A (en) | 1999-04-13 | 2004-01-30 | Anormed Inc | Process for preparing amine platinum complexes |
JP4227701B2 (ja) * | 1999-05-25 | 2009-02-18 | 中部キレスト株式会社 | ジエチレントリアミン五酢酸ルテニウム二アンモニウム塩またはその水和物およびその製法 |
US6489638B2 (en) * | 2000-06-23 | 2002-12-03 | Semiconductor Energy Laboratory Co., Ltd. | Light emitting device |
US6894049B1 (en) | 2000-10-04 | 2005-05-17 | Anormed, Inc. | Platinum complexes as antitumor agents |
US20020072512A1 (en) * | 2000-12-08 | 2002-06-13 | Metaphore Pharmaceuticals, Inc | Method of preventing and treating HIV-mediated central nervous system damage |
GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
AU2003208525B9 (en) * | 2002-02-04 | 2009-08-27 | Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda | Amend the invention title to read Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
GB2395431A (en) * | 2002-11-20 | 2004-05-26 | Northwick Park Inst For Medica | Combination of a metal carbonyl compound and a guanylate cyclase stimulant or stabilizer for the therapeutic delivery of carbon monoxide |
US7737179B2 (en) * | 2003-08-04 | 2010-06-15 | J&J Consumer Companies, Inc. | Methods for treatment of dermatological conditions |
ATE537141T1 (de) * | 2004-02-05 | 2011-12-15 | Kyorin Seiyaku Kk | Bicycloesterderivat |
FR2873037B1 (fr) | 2004-07-13 | 2008-04-11 | Univ Pasteur | Methodes et compositions pour le traitement de cancers |
CA2631389A1 (en) * | 2005-12-21 | 2007-06-28 | Oxford Biosensors Limited | Redox mediators |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
EP1995237A4 (en) | 2006-03-08 | 2011-07-06 | Kyorin Seiyaku Kk | PROCESS FOR PREPARING AN AMINOACETYLPYRROLIDINCARBONITRILE DERIVATIVE AND PRODUCTION PRODUCT THEREOF |
AU2007262635B2 (en) * | 2006-06-23 | 2014-09-11 | Adc Therapeutics Sa | Polynucleotides and polypeptide sequences involved in cancer |
WO2008038305A2 (en) * | 2006-09-26 | 2008-04-03 | Jegannathan Srinivas | Therapeutical formulation comprising a thiazolidinedione and a nitric oxide scavenger. |
JPWO2008114857A1 (ja) | 2007-03-22 | 2010-07-08 | 杏林製薬株式会社 | アミノアセチルピロリジンカルボニトリル誘導体の製造方法 |
CA3050455A1 (en) | 2008-11-03 | 2010-06-03 | Adc Therapeutics Sa | Antibodies that specifically block the biological activity of a tumor antigen |
DE102010014411A1 (de) | 2010-04-08 | 2011-10-13 | Friedrich-Schiller-Universität Jena | Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
DE102010014412A1 (de) | 2010-04-08 | 2012-04-19 | Friedrich-Schiller-Universität Jena | Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe |
KR102140984B1 (ko) | 2011-03-31 | 2020-08-06 | 에이디씨 테라퓨틱스 에스에이 | 신장 결합 항원 1에 대한 항체 및 이의 항원 결합 단편 |
PT2699242T (pt) | 2011-04-19 | 2018-01-22 | Alfama Inc | Moléculas de libertação de monóxido de carbono e utilizações das mesmas |
ES2628634T3 (es) | 2011-07-21 | 2017-08-03 | Alfama, Inc. | Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas |
EP3533468A1 (en) | 2012-01-09 | 2019-09-04 | ADC Therapeutics SA | Method for treating breast cancer |
DE102012004132A1 (de) | 2012-02-29 | 2013-08-29 | Friedrich-Schiller-Universität Jena | Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung |
DE102014008537A1 (de) | 2014-06-04 | 2015-12-17 | Friedrich-Schiller-Universität Jena | Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung |
EP3212610B1 (en) * | 2014-10-30 | 2020-10-28 | Katholieke Universiteit Leuven | Methods for low temperature fluorine-18 radiolabeling of biomolecules |
CN113429456B (zh) * | 2021-06-11 | 2022-05-31 | 首都医科大学 | 多肽衍生物钌类络合物及其制备方法和应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5112974A (en) * | 1985-01-18 | 1992-05-12 | The Trustees Of Columbia University In The City Of New York | Mixed ligand complexes and uses thereof as binding agents to DNA |
US4721669A (en) * | 1985-01-18 | 1988-01-26 | The Trustees Of Columbia University In The City Of New York | Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents |
GB9317686D0 (en) * | 1993-08-25 | 1993-10-13 | Johnson Matthey Plc | Pharmaceutical compositions |
SE9703396D0 (sv) * | 1997-09-19 | 1997-09-19 | Lincoln | Binuclear complex |
-
2000
- 2000-03-17 BR BR0011678-5A patent/BR0011678A/pt not_active Application Discontinuation
- 2000-03-17 PL PL00356683A patent/PL356683A1/xx not_active Application Discontinuation
- 2000-03-17 HU HU0400457A patent/HUP0400457A2/hu unknown
- 2000-03-17 EP EP00910468A patent/EP1163247A1/en not_active Withdrawn
- 2000-03-17 WO PCT/CA2000/000294 patent/WO2000056743A1/en not_active Application Discontinuation
- 2000-03-17 KR KR1020017011819A patent/KR20010112343A/ko not_active Application Discontinuation
- 2000-03-17 CZ CZ20013307A patent/CZ20013307A3/cs unknown
- 2000-03-17 MX MXPA01009410A patent/MXPA01009410A/es unknown
- 2000-03-17 JP JP2000606604A patent/JP2004500321A/ja not_active Withdrawn
- 2000-03-17 CA CA002367282A patent/CA2367282A1/en not_active Abandoned
- 2000-03-17 AU AU32685/00A patent/AU3268500A/en not_active Abandoned
- 2000-03-17 CN CN00806748A patent/CN1391577A/zh active Pending
- 2000-03-17 US US09/527,450 patent/US20020049190A1/en not_active Abandoned
- 2000-03-17 IL IL14529000A patent/IL145290A0/xx unknown
-
2001
- 2001-09-18 NO NO20014526A patent/NO20014526L/no unknown
Also Published As
Publication number | Publication date |
---|---|
US20020049190A1 (en) | 2002-04-25 |
PL356683A1 (en) | 2004-06-28 |
HUP0400457A2 (hu) | 2004-05-28 |
CZ20013307A3 (cs) | 2002-05-15 |
CN1391577A (zh) | 2003-01-15 |
CA2367282A1 (en) | 2000-09-28 |
KR20010112343A (ko) | 2001-12-20 |
AU3268500A (en) | 2000-10-09 |
JP2004500321A (ja) | 2004-01-08 |
WO2000056743A1 (en) | 2000-09-28 |
MXPA01009410A (es) | 2003-06-06 |
IL145290A0 (en) | 2002-06-30 |
EP1163247A1 (en) | 2001-12-19 |
NO20014526D0 (no) | 2001-09-18 |
BR0011678A (pt) | 2002-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20014526L (no) | Farmasöytiske preparater omfattende metallkomplekser | |
EE200200038A (et) | Konservitud farmatseutilised preparaadid | |
IS5953A (is) | Lyfjablöndur úr örgerðum eplerenonum | |
IS6040A (is) | Valdekoxib efnablöndur | |
NO20071303L (no) | Farmasoytiske preparater | |
NO20033556D0 (no) | Farmasöytiske preparater | |
DE60001558D1 (de) | Di- und tri-heteroatom-substituierte metall-indenylkomplexe | |
HK1068812A1 (en) | Drug preparations | |
NO20015175D0 (no) | Farmasöytisk sammensetning | |
PT1173187E (pt) | Preparacoes combinadas compreendendo derivados de antraciclina | |
ATE332132T1 (de) | Verbesserte arzneizubereitungen enthaltend ritonavir | |
NO20022606L (no) | Farmasöytiske kombinasjoner | |
PT1210085E (pt) | Solucoes farmaceuticas de levosimendano | |
NO20014926D0 (no) | Farmasöytiske forbindelser | |
DE69926012D1 (de) | Arzneizubereitungen | |
DE50014688D1 (de) | Bleichaktive Metallkomplexe | |
FI4488U1 (fi) | Farmaseuttinen koostumus | |
NO20016430L (no) | Farmasöytisk kompleks | |
AR025867A1 (es) | Formulacion portasdora farmaceutica | |
DE69906934D1 (de) | Arzneizubereitungen | |
DE50009295D1 (de) | Vernetzerfreie zubereitungen | |
PT1227795E (pt) | Complexos lipidicos de alquiciclinas | |
GB0105865D0 (en) | Pharmaceutical preparations | |
SE9902939D0 (sv) | Pharmaceuticals | |
SE9902940D0 (sv) | Pharmaceuticals |